title: [Prognosis of metabolic syndrome in coronary artery disease patients of different genders].
abstract: OBJECTIVE
  To analyze the prevalence and characteristics of metabolic syndrome (MS) in the patients with coronary artery disease (CAD) of different genders who underwent revascularization.
  
  
  METHODS
  The clinical data of 2596 patients in the DESIRE (Drug-eluting Stent Impact on Revascularization) study who underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) were analyzed and the patients were followed up till death. MS was diagnosed based on the Chinese standard (modified ATP III).
  
  
  RESULTS
  The mean follow-up time was 828.8 +/- 373.2 days. 1139 of the 2596 patients were diagnosed as with MS. The prevalence of MS in the female patients was 50.9%, significantly higher than that in the male patients (41.8%, P < 0.0001). Complication of MS was the only predictive factor of poor prognosis in female CAD patients (OR = 2.019, 95% CI = 1.751 - 2.506, P = 0.023). Fasting blood glucose >or= 110 mg/dl was responsible for most of the increased risk associated with MS (adjusted OR 2.511, 95% CI 1.396 approximately 4.511, P = 0.002).
  
  
  CONCLUSIONS
  In comparison with the male patients the female patients undergoing revascularization have a higher he prevalence of MS and worse prognosis. In the 4 elements of MS hyperglycemia is directly associated with prognosis.
authors.affiliation: Department of Cardiology, Beijing Anzhen Hospital, Capital University of Medical Sciences, Beijing 100029, China.
authors.forename: Rong
authors.initials: R
authors.lastname: Hu
authors.forename: Chang-sheng
authors.initials: CS
authors.lastname: Ma
authors.forename: Shao-ping
authors.initials: SP
authors.lastname: Nie
authors.forename: Qiang
authors.initials: Q
authors.lastname: Lü
authors.forename: Jun-ping
authors.initials: JP
authors.lastname: Kang
authors.forename: Xin
authors.initials: X
authors.lastname: DU
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhang
authors.forename: Ying-chun
authors.initials: YC
authors.lastname: Gao
authors.forename: Li-qun
authors.initials: LQ
authors.lastname: He
authors.forename: Chang-qi
authors.initials: CQ
authors.lastname: Jia
authors.forename: Xin-min
authors.initials: XM
authors.lastname: Liu
authors.forename: Jian-zeng
authors.initials: JZ
authors.lastname: Dong
authors.forename: Xiao-hui
authors.initials: XH
authors.lastname: Liu
authors.forename: Fang
authors.initials: F
authors.lastname: Chen
authors.forename: Yu-jie
authors.initials: YJ
authors.lastname: Zhou
authors.forename: Shu-zheng
authors.initials: SZ
authors.lastname: Lü
authors.forename: Xue-si
authors.initials: XS
authors.lastname: Wu
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002681:China / Q000453:epidemiology; D003324:Coronary Artery Disease / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016015:Logistic Models; D008297:Male; D008659:Metabolic Diseases / Q000150:complications / Q000453:epidemiology / Q000473:pathology*; D008875:Middle Aged; D015995:Prevalence; D011379:Prognosis; D012737:Sex Factors; D015607:Stents; D016019:Survival Analysis; D013577:Syndrome